{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:18:37Z","timestamp":1792084717247,"version":"4.4.0"},"reference-count":59,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T00:00:00Z","timestamp":1149638400000},"content-version":"vor","delay-in-days":1010,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Drug Reviews"],"published-print":{"date-parts":[[2003,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The only current FDA\u2010approved treatment for acute ischemic stroke is thrombolysis with tissue plasminogen activator (tPA). However, there are numerous shortcomings to tPA treatment including an increased incidence of intracerebral hemorrhage (ICH) and a short therapeutic window (3\u20136 h). In recent years, studies have attempted to identify new therapeutics that might be neuroprotective following ischemic strokes. Free radical scavenging spin trap agents have been proposed as potential candidates for stroke therapy because of the hypothesized role of free radicals in the progression of stroke and ischemia\u2010induced neurodegeneration. Novel spin trap agents like (disodium\u2010[(tert\u2010butylimino) methy1] benzene\u20101,3\u2010disulfonate N\u2010oxide (NXY\u2010059) are of particular interest, not only because they are broad\u2010spectrum nitrone\u2010based free radical scavengers, but also because of their safety profile in humans. Moreover, the rationale for developing NXY\u2010059 for the treatment of acute ischemic stroke is further supported by the drug's reported neuroprotective effects. In addition, NXY\u2010059 may represent a useful adjunct stroke therapy to tPA, since preclinical studies have demonstrated that NXY\u2010059 increases the therapeutic window for tPA and lowers the occurrence of tPA\u2010induced ICH.<\/jats:p>","DOI":"10.1111\/j.1527-3458.2003.tb00252.x","type":"journal-article","created":{"date-parts":[[2010,8,14]],"date-time":"2010-08-14T00:26:18Z","timestamp":1281745578000},"page":"253-262","source":"Crossref","is-referenced-by-count":30,"title":["Development of the Nitrone\u2010Based Spin Trap Agent NXY\u2010059 to Treat Acute Ischemic Stroke"],"prefix":"10.1111","volume":"9","author":[{"given":"Paul A.","family":"Lapchak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia M.","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,6,7]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00414-8"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.1707"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1054\/mehy.1997.0627"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-200003000-00002"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s000180050457"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.10.3032"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1016\/S0021-9258(19)50231-9","article-title":"Nitric oxide formation during light\u2010induced decomposition of phenyl N\u2010 tert\u2010butylnitrone","volume":"268","author":"Chamulitrat W","year":"1993","journal-title":"J Biol Chem"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/10715769009145690"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(02)03469-8"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(99)01401-0"},{"key":"e_1_2_1_12_2","article-title":"NXY\u2010059, the first nitrone being developed for stroke, is safe and well tolerated in young and elderly healthy volunteers","volume":"9","author":"Edenius C","year":"1999","journal-title":"Cerebrovasc Dis"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1020221919154"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1373.1999.d01-140.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(99)00443-9"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.11.5057"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.2002.03767.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.2.429"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1139\/y95-051"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.suppl_1.S57"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7742(08)60725-4"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1998.71062549.x"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.30.7.1326"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199812000-00076"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.1999.1.4-481"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1006\/nbdi.1996.0015"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-199907000-00008"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-002-0051-0"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.11.11.1623"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200115110-00001"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000015346.00054.8B"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000017145.22806.AA"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000028267.09604.7B"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.32.3.675"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000053032.14223.81"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-200104000-00003"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(01)00700-6"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1080\/10715760100300351"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.32.1.190"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(99)00270-1"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(98)00010-X"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(98)00257-3"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(00)00170-2"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1998.1086"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1995.120"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2346.1996.00976.x"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.1995.12.943"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8651(18)30033-X"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1999.1159"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-002-0478-x"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704449"},{"key":"e_1_2_1_52_2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0022-2275(20)41174-5","article-title":"Nitrone spin trap lipophilicity as a determinant for inhibition of low density lipoprotein oxidation and activation of interleukin\u20101 beta release from human monocytes","volume":"35","author":"Thomas CE","year":"1994","journal-title":"J Lipid Res"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.6.3097"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(00)00844-2"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006875515357"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)03022-5"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.2000.7364"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(02)02286-2"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(92)90816-R"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(01)02618-X"}],"container-title":["CNS Drug Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1527-3458.2003.tb00252.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1527-3458.2003.tb00252.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T14:58:57Z","timestamp":1700233137000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1527-3458.2003.tb00252.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["10.1111\/j.1527-3458.2003.tb00252.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1527-3458.2003.tb00252.x","archive":["Portico"],"relation":{},"ISSN":["1080-563X","1527-3458"],"issn-type":[{"value":"1080-563X","type":"print"},{"value":"1527-3458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}